1. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus;N Engl J Med,1993
2. Yeh H, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, et al. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. Annals of internal medicine 2012 Sep 4,;157(5):336-347 https://doi.org/10.7326/0003-4819-157-5-201209040-00508.
3. Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters;Wright;Diabetes technology & therapeutics,2017
4. Standardizing Clinically Meaningful Outcome Measures Beyond HbA1cfor Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange
5. Gabbay MAL, Rodacki M, Calliari LE, Vianna AGD, Krakauer M, Pinto MS, et al. Time in range: a new parameter to evaluate blood glucose control in patients with diabetes. Diabetology and metabolic syndrome 2020;12(1):22 https://doi.org/10.1186/s13098-020-00529-z.